UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Post COVID-19 Reflections and Questions: How Prepared Are We for the Next Pandemic?

International journal of molecular sciences, 2024-01, Vol.25 (2), p.859

2024

Volltextzugriff (PDF)

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications

International journal of molecular sciences, 2021-06, Vol.22 (11), p.5546

2021

Volltextzugriff (PDF)

Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7208

2021

Volltextzugriff (PDF)

Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease

Frontiers in bioscience (Elite edition), 2022-07, Vol.14 (3), p.18

2022

Volltextzugriff (PDF)

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology

Molecules, 2015-11, Vol.20 (11), p.20841-20872

2015

Volltextzugriff (PDF)

Dietary and pharmacological factors affecting iron absorption in mice and man (Comment for a Letter to the editor)

Haematologica (Roma), 2016-03, Vol.101 (3), p.e120-e121

2016

Volltextzugriff (PDF)

Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

Current medicinal chemistry, 2005-11, Vol.12 (23), p.2663-2681

2005

Volltextzugriff (PDF)

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications

Medicines (Basel, Switzerland), 2020-07, Vol.7 (8), p.45

2020

Volltextzugriff (PDF)

Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease: the role of natural and synthetic chelators

Current medicinal chemistry, 2005-01, Vol.12 (23), p.2695-2709

2005

Volltextzugriff (PDF)

Chelation protocols for the elimination and prevention of iron overload in thalassaemia

Frontiers in bioscience, 2018-01, Vol.23 (6), p.1082-1098, Article 4634

2018

Volltextzugriff (PDF)

Myocyte Damage and Loss of Myofibers is the Potential Mechanism of Iron Overload Toxicity in Congestive Cardiac Failure in Thalassemia. Complete Reversal of the Cardiomyopathy and Normalization of Iron Load by Deferiprone

Hemoglobin, 2008, Vol.32 (1-2), p.17-28

2008

Volltextzugriff (PDF)

Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy

European journal of haematology, 2010-11, Vol.85 (5), p.430-438

2010

Volltextzugriff (PDF)

Antioxidant targeting by deferiprone in diseases related to oxidative damage

Frontiers in bioscience, 2014-06, Vol.19 (6), p.862-885

2014

Volltextzugriff (PDF)

Prevention of Iron Overload and Long Term Maintenance of Normal Iron Stores in Thalassaemia Major Patients using Deferiprone or Deferiprone Deferoxamine Combination

Drug research, 2017-07, Vol.67 (7), p.404-411

2017

Volltextzugriff (PDF)

New targeted therapies and diagnostic methods for iron overload diseases

Frontiers in bioscience (Scholar edition), 2018-01, Vol.10 (1), p.1-20, Article 498

2018

Volltextzugriff (PDF)

Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals

Expert opinion on investigational drugs, 2013-05, Vol.22 (5), p.591-618

2013

Volltextzugriff (PDF)

The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study

Scientific reports, 2016-05, Vol.6 (1), p.26371-26371, Article 26371

2016

Volltextzugriff (PDF)

Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2

Toxicology mechanisms and methods, 2013-01, Vol.23 (1), p.48-56

2013

Volltextzugriff (PDF)

New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores

British journal of haematology, 2010-08, Vol.150 (4), p.489-490

2010

Volltextzugriff (PDF)

The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies

Hemoglobin, 2010-06, Vol.34 (3), p.227-239

2010

Volltextzugriff (PDF)

The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients

Toxicology mechanisms and methods, 2013-01, Vol.23 (1), p.34-41

2013

Volltextzugriff (PDF)

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements

Journal of clinical medicine, 2019-11, Vol.8 (11), p.1959

2019

Volltextzugriff (PDF)

Efficacy, Compliance And Toxicity Factors Are Affecting The Rate Of Normalization Of Body Iron Stores In Thalassemia Patients Using The Deferiprone And Deferoxamine Combination Therapy

Hemoglobin, 2011-06, Vol.35 (3), p.186-198

2011

Volltextzugriff (PDF)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor

Mediterranean journal of hematology and infectious diseases, 2017-10, Vol.9 (1), p.e2017060-e2017060

2017

Volltextzugriff (PDF)

Gene Therapy Getting Personal: Mutation-Specific Editing and Gene Addition Strategies for β-Thalassaemia

Hemoglobin, 2019-11, Vol.43 (6), p.330-330

2019

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(48)
Berichte
(2)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Deferiprone
(23)
Iron Chelating Agents - Therapeutic Use
(21)
Hematology
(19)
Biochemistry & Molecular Biology
(18)
Deferoxamine
(18)
Deferoxamine - Therapeutic Use
(16)
Pyridones - Therapeutic Use
(16)
Chelation Therapy
(14)
Female
(14)
Iron - Metabolism
(14)
Iron Overload
(14)
Iron Overload - Drug Therapy
(14)
Male
(13)
Drug Therapy, Combination
(11)
Adult
(10)
Iron
(10)
Thalassaemia
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Post COVID-19 Reflections and Questions: How Prepared Are We for the Next Pandemic?

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications

Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave

Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology

Dietary and pharmacological factors affecting iron absorption in mice and man (Comment for a Letter to the editor)

Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications

Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease: the role of natural and synthetic chelators

Chelation protocols for the elimination and prevention of iron overload in thalassaemia

Myocyte Damage and Loss of Myofibers is the Potential Mechanism of Iron Overload Toxicity in Congestive Cardiac Failure in Thalassemia. Complete Reversal of the Cardiomyopathy and Normalization of Iron Load by Deferiprone

Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy

Antioxidant targeting by deferiprone in diseases related to oxidative damage

Prevention of Iron Overload and Long Term Maintenance of Normal Iron Stores in Thalassaemia Major Patients using Deferiprone or Deferiprone Deferoxamine Combination

New targeted therapies and diagnostic methods for iron overload diseases

Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals

The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study

Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2

New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores

The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies

The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements

Efficacy, Compliance And Toxicity Factors Are Affecting The Rate Of Normalization Of Body Iron Stores In Thalassemia Patients Using The Deferiprone And Deferoxamine Combination Therapy

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor

Gene Therapy Getting Personal: Mutation-Specific Editing and Gene Addition Strategies for β-Thalassaemia

Suchergebnisse filtern